PharmaVentures Revenue and Competitors

Oxford,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • PharmaVentures's estimated annual revenue is currently $10.3M per year.(i)
  • PharmaVentures's estimated revenue per employee is $201,000

Employee Data

  • PharmaVentures has 51 Employees.(i)
  • PharmaVentures grew their employee count by 16% last year.

PharmaVentures's People

NameTitleEmail/Phone
1
VPReveal Email/Phone
2
VP Corporate Advisory BusinessReveal Email/Phone
3
VP - StrategyReveal Email/Phone
4
Head Business Development & MarketingReveal Email/Phone
5
Non Executive DirectorReveal Email/Phone
6
DirectorReveal Email/Phone
7
Non-Executive DirectorReveal Email/Phone
8
DirectorReveal Email/Phone
9
Senior DirectorReveal Email/Phone
10
Senior Marketing ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is PharmaVentures?

PharmaVentures is a premier transaction advisory firm and a leading international company in partnering, M&A deals and strategic alliances. For the past 28 years, PharmaVentures has acted as advisor on over 900 deal related projects covering licensing, mergers, acquisitions, divestments, and joint venture activities for companies worldwide. PharmaVentures' deep bank of specialist experience, deal analytics and network of contacts from innovators to large pharma makes us uniquely placed to support business in all aspects of deal making and strategic planning. PharmaVentures is well known for its deep insight into deal structures and its success for generating partnering interest. PharmaVentures also provides advice on valuation of businesses, R&D assets as well as market assessments. For example, in March 2014 PharmaVentures was engaged by Tiziana Life Sciences, plc to provide independent valuation advice for assets acquired as part of it Admission to AIM (London Stock Exchange). Clients originate from the following countries: USA; Canada; United Kingdom; Europe; India, Japan; Korea; Australia; New Zealand; Brazil; Chile; South Africa; UAE.

keywords:N/A

N/A

Total Funding

51

Number of Employees

$10.3M

Revenue (est)

16%

Employee Growth %

N/A

Valuation

N/A

Accelerator

PharmaVentures News

2022-03-22 - PharmaVentures advises Lausanne Hospital (CHUV) and ...

PharmaVentures advises Lausanne Hospital (CHUV) and EPFL on their collaboration and founding of Aerium Therapeutics to develop their highly...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.9M516%N/A
#2
$10.7M52-7%N/A
#3
$8.4M52136%N/A
#4
$14.4M52-2%N/A
#5
$3.5M548%N/A